title: Bevacizumab-induced laryngeal necrosis.
authors: Department of Head and Neck Oncology, Institut Gustave Roussy, Villejuif. Electronic address: dana.hartl@igr.fr.
authors: D M
authors: DM
authors: Hartl
authors: Department of Medical Oncology-SITEP (Service des Innovations Thérapeutiques Précoces), Institut Gustave Roussy, Villejuif.
authors: R
authors: R
authors: Bahleda
authors: Department of Medical Oncology-SITEP (Service des Innovations Thérapeutiques Précoces), Institut Gustave Roussy, Villejuif.
authors: A
authors: A
authors: Hollebecque
authors: Department of Pathology, Institut Gustave Roussy, Villejuif, France.
authors: J
authors: J
authors: Bosq
authors: Department of Medical Oncology-SITEP (Service des Innovations Thérapeutiques Précoces), Institut Gustave Roussy, Villejuif.
authors: C
authors: C
authors: Massard
authors: Department of Medical Oncology-SITEP (Service des Innovations Thérapeutiques Précoces), Institut Gustave Roussy, Villejuif.
authors: J C
authors: JC
authors: Soria
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D017321:Clinical Trials, Phase I as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005971:Glutamates / Q000008:administration & dosage; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D007818:Laryngeal Diseases / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009336:Necrosis / Q000139:chemically induced; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D017239:Paclitaxel / Q000008:administration & dosage; D000068437:Pemetrexed; D050257:Tubulin Modulators / Q000008:administration & dosage; D000093542:Gemcitabine
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D005971:Glutamates; D050257:Tubulin Modulators; D000068437:Pemetrexed; D003841:Deoxycytidine; D000068258:Bevacizumab; D006147:Guanine; D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin; D000093542:Gemcitabine